You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Preclinical Development of Semisynthetic Saponin Immunological Adjuvant Titerquil-1055 in the Context of an Influenza Vaccine
SBC: ADJUVANCE TECHNOLOGIES INC. Topic: NIAIDIncreasingly defined vaccines against infectious diseases are better tolerated but less immunogenicrequiring use of an immunological adjuvant for best effectAdjuvance s semi synthetic saponin adjuvant TiterQuilTQLhas shown remarkable efficacy with a variety of antigens with no detectable reactogenicityWhen combined withof the leading vaccines against influenzaFluzoneFluarix and Flublokstriking aug ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A Liposomal Platform for Spontageous, Particleized Presentation of HIV Trimer Immunogens
SBC: POP Biotechnologies Inc. Topic: NIAIDOver one million Americans andmillion people worldwide are infected with HIVmaking it one of the most pressing public health concerns of our timeUnfortunatelythere are no vaccines available and treatment requires lifelong anti retroviral therapiesThis proposal combines two technologies for the development of a vaccine against HIVEnva novel adjuvantspontaneous nanoliposome antigen particleizationSN ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
SBIR PHASE 1: SCALABLE DIGITAL DELIVERY OF EVIDENCE-BASED TRAINING FOR FAMILY TO MAXIMIZE TREATMENT ADMISSION RATES OF OPIOID USE DISORDER IN LOVED ONES.
SBC: WE THE VILLAGE, INC. Topic: NIDAThe project goal is to develop digital delivery of Community Reinforcement and Family TrainingCRAFTmethodologyan empirical family behavioral intervention to improve outcomes around treatment entryfamily functioning and substance use
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Towards in vivo high-definition 3D corneal imaging
SBC: LighTopTech Corp. Topic: NEIThe corneathe outermost window of our visual systemis vulnerable to various types of infections and diseasesCorneal disease is one of the leading causes of visual deficiency and blindness !There are nearlymillion bilaterally corneal blind persons worldwideand an estimatedmillion people affected by unilateral corneal blindness globallyIn a conservative estimatecorneal diseases affect nearlypeople i ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
An antigen-capture assay to screen donated blood for Babesia microti
SBC: BIOPEPTIDES CORP Topic: NIAIDPROJECT SUMMARY In the U.S. ~5 million individuals receive blood transfusions annually. Increasingly, these recipients are being put at risk of infection with Babesia microti, a tick-transmitted blood-borne parasite that resides in red blood cells (RBCs) and causes the disease babesiosis. B. microti represents a significant threat to the US blood supply as it survives blood banking procedures and ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
New high-throughput screening technologies to improve cannabinoid production in yeast.
SBC: LUCERNA INC Topic: NCCIHSUMMARY Natural products derived from plants have played crucial roles in the treatments of many diseases throughout historyHoweverscarce natural sources and complex chemical synthesis have limited research and development and increased costs on these productsAn example of this is the non psychoactive cannabinoids found in cannabis plantsThere are overlow abundant cannabinoids that are known to be ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Automatic SUV Extraction and Biodistribution Analysis of Preclinical PET
SBC: IN VIVO ANALYTICS, INC. Topic: 100Preclinical positron emission tomographyPETplays a significant role in monitoring radiotracer biodistributions for the development of new therapiesThe standardized uptake valueSUVhas become one of the most important quantitation measures in PET analysisHoweverSUV extraction from PET data hinges on the ability to clearly delineate the organ region of interestROIfrom an anatomical referenceCross com ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of broadly neutralizing antibodies to treat hantavirus infections
SBC: Ichor Biologics LLC Topic: NIAIDPROJECT SUMMARY Hantaviruses are an emerging family of highly pathogenic viruses that cause 100-200,000 cases of two severe febrile illnesses a year; Hantavirus cardiopulmonary syndrome (HCPS) and hemorrhagic fever with renal syndrome (HFRS). While the annual incidence of infections are relatively low compared to other viral infections, some hantavirus strains are particularly deadly, causing a 35 ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A high-throughput cell-free profiling platform integrating high metabolic diversity for chemical safety assessment
SBC: ZYMTRONIX CATALYTIC SYSTEMS, INC. Topic: NIEHSAbstract Roughlynew drugs and chemicals are commercialized each year successfully clearing research and developmentRandamp Dhurdles to meet the safety requirements of regulators such as the U SFood and Drug AdministrationThese successeshoweverare the exception rather than the rule making it advantageous for Randamp D programs to have methods in place that ensure unsafe compoundsfail fastwell befor ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
MicroRNA-based Diagnostic Biomarker for Pulmonary Hypertension
SBC: MIRNA ANALYTICS LLC Topic: NHLBIAbstract Mirna Analytics is proposing to develop a microRNAmiRNAmarker for pulmonary hypertensionThis proposal is focused on the identification of optimal miRNAandapos s to form composite markers that can be measured in the serum plasmaPulmonary hypertensionan excessive increase of the pressure in the pulmonary circulationcan be due to many different reasonsPulmonary hypertension can be a deadly d ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health